| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = -$1,983,590 ) |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01AR082324 | High throughput isotropic resolution fluorescence and second Harmonic imaging to characterize tendon injury | 000 | 3 | NIH | 11/28/2025 | $395,246 |
| | 2026 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | NU65PS923777 | Capacity Building Assistance (CBA) for HIV Prevention Programs to End the HIV Epidemic in the United States | 01 | 2 | CDC | 11/13/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R35HL155008 | TRP channels as fundamental sensors of the cerebral microcirculation | 000 | 5 | NIH | 11/21/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R56AR085145 | Deciphering the endotypes and signature of non-response in a humanized murine model of PsA | 000 | 1 | NIH | 11/28/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01DK136064 | GSTM1-Transsulfuration metabolic axis in kidney disease: therapeutic target in precision medicine | 000 | 2 | NIH | 11/18/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | P30ES001247 | Environmental Agents as Modulators of Disease Processes | 000 | 50 | NIH | 11/26/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | F31CA284555 | Identification and structural basis of a potential licensing factor of the Integrator cleavage module | 000 | 2 | NIH | 12/2/2025 | -$21,567 |
| | 2026 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | NU65PS923777 | Capacity Building Assistance (CBA) for HIV Prevention Programs to End the HIV Epidemic in the United States | 01 | 2 | CDC | 11/13/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | UL1TR002001 | The University of Rochester Clinical and Translational Science Award Hub | 000 | 9 | NIH | 11/26/2025 | -$1,996,698 |
| | 2026 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | UG3OD023349 | Common Mechanisms linking Pre- and Post-Natal Exposures for Child Health Outcomes | 000 | 9 | NIH | 11/17/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R21AI174848 | SMC1A/3 cohesin complex-mediated silencing of unintegrated HIV-1 DNA and the antagonism by Vpr | 000 | 2 | NIH | 11/24/2025 | -$335 |
| | 2026 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01MD018573 | Association of the redesigned Comprehensive Care for Joint Replacement model with racial/ethnic and socioeconomic disparities in joint replacement surgeries | 000 | 2 | NIH | 11/28/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01AG082890 | Family of Origin Bilingualism and ADRD: An Epidemiologic Study of 377,000 Older Adults in the US | 000 | 2 | NIH | 11/25/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | K01NR020504 | Neural Network Approach to Estimate Fetal Weight in the Late Third Trimester of Pregnancy | 000 | 3 | NIH | 11/24/2025 | -$13,923 |
| | 2026 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | K23DC018303 | The Development of Vestibular-Perceptual Adaptation Paradigms for Treating Persistent Vertigo & Perceived Disequilibrium | 000 | 5 | NIH | 11/25/2025 | -$430 |
| | 2026 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | KL2TR001999 | Institutional Career Development Core | 000 | 9 | NIH | 11/26/2025 | -$344,669 |
| | 2026 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | F31ES035614 | NIH Plunk The Effects of Gestational and Lactational Exposure to Perfluorohexanoic Acid on Cerebellum Development in the Mouse | 000 | 2 | NIH | 11/26/2025 | -$1,214 |
| | 2026 | 2023 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R03NS134395 | Automated Machine Learning-Based Brain Artery Segmentation, Anatomical Prior Labeling, and Feature Extraction on MR Angiography | 000 | 1 | NIH | 11/26/2025 | $0 |
| | 2026 | 2021 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | K24NS126861 | Promoting high-quality pain treatment trials through mentorship of junior investigators: A focus on study conduct and method development | 000 | 1 | NIH | 11/20/2025 | $0 |
|
 | Issue Date FY: 2025 ( Subtotal = $194,567,722 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | F30DC023436 | Olfactory Coding in Ventral CA1 Region of the Hippocampus | 001 | 1 | NIH | 8/28/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01AR086382 | Pathophysiology of Tubular Aggregate Myopathy | 000 | 1 | NIH | 8/5/2025 | $1,676,733 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | F30DC023436 | Olfactory Coding in Ventral CA1 Region of the Hippocampus | 000 | 1 | NIH | 8/28/2025 | $54,538 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | K99HL171851 | Characterizing determinants of cellular senescence and epigenetic dysregulation on tobacco smoke exposure in lung | 000 | 1 | NIH | 8/26/2025 | $113,683 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R21AI189268 | Novel Mechanisms of CD4-Independent Immunity Against Pneumocystis | 000 | 1 | NIH | 7/1/2025 | $226,500 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01NS136626 | Statistical Methods for Confocal Microscopy Images of Microglia | 000 | 2 | NIH | 3/4/2025 | $346,500 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01MH128279 | Protein phosphatase 1 isoforms, human de novo mutations and synaptic functions | 001 | 3 | NIH | 3/5/2025 | $38,123 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01MH128279 | Protein phosphatase 1 isoforms, human de novo mutations and synaptic functions | 000 | 3 | NIH | 2/19/2025 | $488,733 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | S10OD036451 | Enabling Anatomical, Functional, and Molecular Imaging by Upgrading a Vevo 3100 to Vevo F2-LAZR-X Ultrasound and Photoacoustic Scanner | 000 | 1 | NIH | 7/31/2025 | $923,205 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | S15OD039772 | Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (S15 Clinical Trial Not Allowed) | 000 | 1 | NIH | 8/1/2025 | $350,000 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R34NS143690 | Selective Targeting of Cognitive Control Subnetworks with Spatiotemporally Optimized Transcranial Electrical Stimulation | 000 | 1 | NIH | 7/31/2025 | $346,500 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01GM153936 | Iterative Cyclization Strategies for Complex Molecule Synthesis | 001 | 2 | NIH | 8/6/2025 | $31,570 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01GM153936 | Iterative Cyclization Strategies for Complex Molecule Synthesis | 000 | 2 | NIH | 2/17/2025 | $284,130 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R13NS145603 | Third Consensus Meeting on Neurocognitive and Functional Endpoints in MPS Clinical Studies | 000 | 1 | NIH | 7/24/2025 | $15,000 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01MD019748 | Actívatexto: Advancing smoking cessation and physical activity among Latinos | 001 | 2 | NIH | 7/29/2025 | $768,291 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R35GM156247 | Genetic constraints on adaptive evolution | 000 | 1 | NIH | 7/23/2025 | $227,435 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01GM052347 | tRNA Processing | 003 | 30 | NIH | 8/7/2025 | $45,900 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01GM052347 | tRNA Processing | 002 | 30 | NIH | 2/17/2025 | $413,102 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01GM052347 | tRNA Processing | 001 | 29 | NIH | 2/12/2025 | $413,102 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | F31NS145536 | Using iPSCs to model the combined effects of genetics and aging on the human blood-brain barrier | 000 | 1 | NIH | 7/31/2025 | $49,538 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | F31NS145536 | Using iPSCs to model the combined effects of genetics and aging on the human blood-brain barrier | 001 | 1 | NIH | 7/31/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R21ES037434 | Cell Specific Proteomics highlights Molecular signatures of Manganese neurotoxicity in Dopaminergic neurons in vivo | 000 | 1 | NIH | 8/5/2025 | $464,133 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | UM1TR005451 | University of Rochester CTSA Hub | 000 | 1 | NIH | 8/7/2025 | $3,471,094 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | T32AR076950 | Training in Musculoskeletal Science | 001 | 6 | NIH | 5/23/2025 | $111,760 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R00HL161406 | Spatiotemporal visualization of adenylyl cyclase signaling | 000 | 3 | NIH | 7/30/2025 | $249,000 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | F32EY035963 | The spatial and temporal dynamics of neural interactions underlying attention-related enhancement and suppression of visual processing | 001 | 1 | NIH | 9/24/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | F32EY035963 | The spatial and temporal dynamics of neural interactions underlying attention-related enhancement and suppression of visual processing | 000 | 1 | NIH | 8/28/2025 | $80,224 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01AR085590 | Investigation in the role of L-type Ca2+ channel CaV1.2 in Achilles tendinopathy | 000 | 1 | NIH | 6/18/2025 | $464,315 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01NS127901 | Brain Mechanisms of Chronic Low-Back Pain: Specificity and Effects of Aging and Sex | 000 | 3 | NIH | 3/4/2025 | $438,830 |
|